Post-authorization safety study to check the potential association between the safety profile of beta interferon 1a and the body mass index or pharmacodynamics during the titration phase
Latest Information Update: 14 Apr 2022
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Merck Serono
Most Recent Events
- 14 Apr 2022 New trial record